252 related articles for article (PubMed ID: 10590778)
41. Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening.
LaMontagne DS; Fenton KA; Randall S; Anderson S; Carter P
Sex Transm Infect; 2004 Oct; 80(5):335-41. PubMed ID: 15459399
[TBL] [Abstract][Full Text] [Related]
42. Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials.
Gottlieb SL; Xu F; Brunham RC
Sex Transm Dis; 2013 Feb; 40(2):97-102. PubMed ID: 23324973
[TBL] [Abstract][Full Text] [Related]
43. Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: results from the first national population based study in the Netherlands.
van Bergen J; Götz HM; Richardus JH; Hoebe CJ; Broer J; Coenen AJ;
Sex Transm Infect; 2005 Feb; 81(1):17-23. PubMed ID: 15681716
[TBL] [Abstract][Full Text] [Related]
44. Follow-up, treatment, and reinfection rates among asymptomatic chlamydia trachomatis cases in general practice.
van Valkengoed IG; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; van Eijk JT; Boeke AJ
Br J Gen Pract; 2002 Aug; 52(481):623-7. PubMed ID: 12171219
[TBL] [Abstract][Full Text] [Related]
45. Effects of screening and partner notification on Chlamydia positivity in the United States: a modeling study.
Kretzschmar M; Satterwhite C; Leichliter J; Berman S
Sex Transm Dis; 2012 May; 39(5):325-31. PubMed ID: 22504590
[TBL] [Abstract][Full Text] [Related]
46. Which treatment for genital tract Chlamydia trachomatis infection?
Tobin JM; Harindra V; Mani R
Int J STD AIDS; 2004 Nov; 15(11):737-9. PubMed ID: 15537459
[TBL] [Abstract][Full Text] [Related]
47. The cost-effectiveness of screening men for Chlamydia trachomatis: a review of the literature.
Gift TL; Blake DR; Gaydos CA; Marrazzo JM
Sex Transm Dis; 2008 Nov; 35(11 Suppl):S51-60. PubMed ID: 18520977
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of partner notification for Chlamydia trachomatis among young adults in youth health centres in Uppsala County, Sweden.
Sylvan SP; Hedlund J
J Eur Acad Dermatol Venereol; 2009 May; 23(5):517-22. PubMed ID: 19207561
[TBL] [Abstract][Full Text] [Related]
49. The English National Chlamydia Screening Programme: variations in positivity in 2007/2008.
Simms I; Talebi A; Rhia J; Horner P; French RS; Sarah R; Macintosh M
Sex Transm Dis; 2009 Aug; 36(8):522-7. PubMed ID: 19455079
[TBL] [Abstract][Full Text] [Related]
50. Screening for chlamydia in general practice.
Heal C; Jones B; Veitch C; Lamb S; Hodgens S; Browning S; Butler H; Carey M
Aust Fam Physician; 2002 Aug; 31(8):779-82. PubMed ID: 12189675
[TBL] [Abstract][Full Text] [Related]
51. Chlamydia detection and management.
Dayan L
Aust Fam Physician; 2000 Jun; 29(6):522-6. PubMed ID: 10863806
[TBL] [Abstract][Full Text] [Related]
52. [Towards screening for Chlamydia trachomatis].
Kolmos HJ
Ugeskr Laeger; 1997 Aug; 159(34):5104-5. PubMed ID: 9297316
[No Abstract] [Full Text] [Related]
53. Evaluating adolescents in juvenile detention facilities for urogenital chlamydial infection: costs and effectiveness of alternative interventions.
Mrus JM; Biro FM; Huang B; Tsevat J
Arch Pediatr Adolesc Med; 2003 Jul; 157(7):696-702. PubMed ID: 12860793
[TBL] [Abstract][Full Text] [Related]
54. Cost-effectiveness analysis of Chlamydia trachomatis screening in Dutch pregnant women.
Rours GI; Smith-Norowitz TA; Ditkowsky J; Hammerschlag MR; Verkooyen RP; de Groot R; Verbrugh HA; Postma MJ
Pathog Glob Health; 2016; 110(7-8):292-302. PubMed ID: 27958189
[TBL] [Abstract][Full Text] [Related]
55. Factors influencing women's views on the acceptability and experience of being opportunistically screened for Chlamydia trachomatis in hospital settings.
McMillan LE; Norman JE; Murray K; Reid ME
Int J STD AIDS; 2006 Dec; 17(12):821-5. PubMed ID: 17212859
[TBL] [Abstract][Full Text] [Related]
56. Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease.
Howell MR; Gaydos JC; McKee KT; Quinn TC; Gaydos CA
Sex Transm Dis; 1999 Oct; 26(9):519-26. PubMed ID: 10534206
[TBL] [Abstract][Full Text] [Related]
57. Screening for Chlamydia trachomatis; the Amsterdam experience.
Bleker OP
Minerva Ginecol; 2000 Dec; 52(12 Suppl 1):97-9. PubMed ID: 11526697
[No Abstract] [Full Text] [Related]
58. Novel interventions to reduce re-infection in women with chlamydia: a randomized controlled trial.
Cameron ST; Glasier A; Scott G; Young H; Melvin L; Johnstone A; Elton R
Hum Reprod; 2009 Apr; 24(4):888-95. PubMed ID: 19136481
[TBL] [Abstract][Full Text] [Related]
59. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up.
Morré SA; van den Brule AJ; Rozendaal L; Boeke AJ; Voorhorst FJ; de Blok S; Meijer CJ
Int J STD AIDS; 2002 Dec; 13 Suppl 2():12-8. PubMed ID: 12537719
[TBL] [Abstract][Full Text] [Related]
60. Lessons learned from a population-based chlamydia screening pilot.
Götz HM; van Bergen JE; Veldhuijzen IK; Hoebe CJ; Broer J; Coenen AJ; de Groot F; Verhooren MJ; van Schaik DT; Richardus JH
Int J STD AIDS; 2006 Dec; 17(12):826-30. PubMed ID: 17212860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
